| SP003 inhibits multiple pathways leading to inflammation, including the release of Prostaglandins I2, E 2, and D2; NF-kB and Cox-2,
Competition:Competition: Inhaled corticosteroids, Inhaled cromolyn (Intal®), and inhaled nedocromil (Tilade®) |
- Potent anti-inflammatory activity
- Oral administration
- Improved compliance
- Improved asthma management
|
